SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000899866-21-000009
Filing Date
2021-02-04
Accepted
2021-02-04 08:13:06
Documents
16
Period of Report
2021-02-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K alxn-20210204.htm   iXBRL 8-K 33837
2 EX-99.1 earningsreleaseq42020.htm EX-99.1 355727
8 a2016earningsreleaseimagea.jpg GRAPHIC 12335
  Complete submission text file 0000899866-21-000009.txt   581290

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alxn-20210204.xsd EX-101.SCH 2452
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alxn-20210204_cal.xml EX-101.CAL 741
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alxn-20210204_def.xml EX-101.DEF 1687
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alxn-20210204_lab.xml EX-101.LAB 24275
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alxn-20210204_pre.xml EX-101.PRE 12677
9 EXTRACTED XBRL INSTANCE DOCUMENT alxn-20210204_htm.xml XML 10827
Mailing Address 121 SEAPORT BOULEVARD BOSTON MA 02210
Business Address 121 SEAPORT BOULEVARD BOSTON MA 02210 4752302596
ALEXION PHARMACEUTICALS, INC. (Filer) CIK: 0000899866 (see all company filings)

IRS No.: 133648318 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27756 | Film No.: 21588919
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences